For instance, the downregulation or mutation in tumor suppressors AXIN2 and APC in BRAF-mutant CRC, as observed in our study, agrees with previous reports linking BRAF mutations to the dysregulation of the Wnt/β-catenin signaling pathway [48,79]. The gene discussed is AXIN2; the disease is colorectal carcinoma.